Concepedia

P Tagliaferri

PT

Statistics

Publications

6

Citations

373

H-Index

6

Active since

1985

Affiliations

National Cancer Institute(Current)

University of Naples Federico II

P Tagliaferri is an author at National Cancer Institute specializing in pharmacology, cell signaling, and signal transduction.

Publications per year

1985–2000

6

Publications

6

Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.

P Tagliaferri, Dionyssios Katsaros, Timothy Clair et al. · PubMed · 1988 · 102 citations

, , +15

Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients

Giampaolo Tortora, Fortunato Ciardiello, Stefano Pepe et al. · PubMed · 1995 · 71 citations

, , +17

Site-selective cAMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic, and acute lymphocytic human leukemia cell lines

Giampaolo Tortora, P Tagliaferri, Timothy Clair et al. · Blood · 1988 · 68 citations · Full text

, , +7

Reverse transformation of Harvey murine sarcoma virus-transformed NIH/3T3 cells by site-selective cyclic AMP analogs.

P Tagliaferri, Dionyssios Katsaros, Timothy Clair et al. · Journal of Biological Chemistry · 1988 · 56 citations · Full text

, , +11

Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study

Elide Matano, P Tagliaferri, Annamaria Libroia et al. · British Journal of Cancer · 2000 · 49 citations · Full text

, , +15

1–5 of 6